Pete Williams
banner
petetheteapot.bsky.social
Pete Williams
@petetheteapot.bsky.social
Tea drinker and scientist. Neurons, NAD, stuff.

Professor in Vision Science, Research Group Leader - Glaucoma at Karolinska Institutet and St. Erik Eye Hospital, Stockholm (petewilliamslab.com)

CEO - Mim Neurosciences (mimneurosciences.com)
* snort *
March 7, 2025 at 10:24 AM
"[The] findings indicate that young children with AIPL1-related retinal dystrophy benefited substantially from subretinal administration of rAAV8.hRKp.AIPL1, with improved visual acuity and functional vision and evidence of some protection against progressive retinal degeneration [...]."
February 21, 2025 at 10:17 AM
Bingo. F&A (equivalent of our SA + INDI + rent) is additive to the direct (research costs). Which is a pretty good gig when an R01 maxes out at 500k (5 MSEK) a year (not that everyone gets funded at the top level).
February 8, 2025 at 8:23 PM
I've been itching to post this with fear of being canceled haha!

100% agree. The powerful thing with the NIH is overheads AFTER research budget, not as part of.

Imagine how far our KI money would go if we didn't lose 20-25% in admin + rent + 55% on social security ...
February 8, 2025 at 4:52 PM